Pelerin D, Silvestre R M, Jérusalem G, Sautois B, Polus M, Fillet G
Université de Liège.
Rev Med Liege. 2002 Dec;57(12):755-6.
Thromboembolic complications are well known side effects of treatment with tamoxifen in patients with breast cancer. The authors review the pathophysiology and the risk factors that increase the probability to develop these complications. The most appropriate treatment is discussed.
血栓栓塞并发症是乳腺癌患者使用他莫昔芬治疗时众所周知的副作用。作者回顾了其病理生理学以及增加发生这些并发症可能性的危险因素，并讨论了最恰当的治疗方法。
